- Home
- MPB vs AMLX Comparison
MPB vs AMLX Comparison
Compare MPB & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPB
- AMLX
- Stock Information
- Founded
- MPB 1868
- AMLX 2014
- Country
- MPB United States
- AMLX United States
- Employees
- MPB N/A
- AMLX N/A
- Industry
- MPB Major Banks
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- MPB Finance
- AMLX Health Care
- Exchange
- MPB Nasdaq
- AMLX Nasdaq
- Market Cap
- MPB 695.0M
- AMLX 749.9M
- IPO Year
- MPB N/A
- AMLX 2022
- Fundamental
- Price
- MPB $30.35
- AMLX $10.44
- Analyst Decision
- MPB Buy
- AMLX Strong Buy
- Analyst Count
- MPB 2
- AMLX 7
- Target Price
- MPB $34.50
- AMLX $12.29
- AVG Volume (30 Days)
- MPB 78.4K
- AMLX 1.3M
- Earning Date
- MPB 10-22-2025
- AMLX 11-06-2025
- Dividend Yield
- MPB 2.64%
- AMLX N/A
- EPS Growth
- MPB N/A
- AMLX N/A
- EPS
- MPB 2.30
- AMLX N/A
- Revenue
- MPB $191,454,000.00
- AMLX N/A
- Revenue This Year
- MPB $24.57
- AMLX N/A
- Revenue Next Year
- MPB $12.23
- AMLX N/A
- P/E Ratio
- MPB $13.19
- AMLX N/A
- Revenue Growth
- MPB 13.34
- AMLX N/A
- 52 Week Low
- MPB $22.50
- AMLX $2.28
- 52 Week High
- MPB $33.87
- AMLX $10.55
- Technical
- Relative Strength Index (RSI)
- MPB 66.49
- AMLX 71.59
- Support Level
- MPB $28.08
- AMLX $9.15
- Resistance Level
- MPB $30.73
- AMLX $10.06
- Average True Range (ATR)
- MPB 0.64
- AMLX 0.56
- MACD
- MPB 0.09
- AMLX 0.13
- Stochastic Oscillator
- MPB 85.66
- AMLX 96.23
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.